Professor of Psychiatry and Pharmacology, Head, Mood Disorders Psychopharmacology Unit, University of Toronto, Toronto, Canada; Chairman and Executive Director, Brain and Cognition Discovery Foundation, Toronto, Canada; Director, Depression and Bipolar Support Alliance, Chicago, Illinois; Professor and Nanshan Scholar, Guangzhou Medical University, Guangzhou, China
Roger McIntyre, MD, FRCPC, is currently a professor of psychiatry and pharmacology at the University of Toronto and head of the Mood Disorders Psychopharmacology Unit at the University Health Network, in Toronto, Ontario, Canada. Dr. McIntyre is also chairman and executive director of the Brain and Cognition Discovery Foundation, also in Toronto, Ontario, Canada. Dr. McIntyre is also director for the Depression and Bipolar Support Alliance (DBSA) in Chicago, IL, and professor and Nanshan Scholar at Guangzhou Medical University, in Guangzhou, China, and adjunct professor at the College of Medicine at Korea University, in Seoul, South Korea. Dr. McIntyre is also a clinical professor at the State University of New York (SUNY) Upstate Medical University in Syracuse, NY, and a clinical professor in the Department of Psychiatry and Neurosciences at the University of California School of Medicine in Riverside, CA.
Dr. McIntyre was named by Clarivate Analytics/Thomson Reuters in 2014, 2015, 2016, 2017, and 2018 as one of “The World’s Most Influential Scientific Minds.” This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.
Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.
Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry, and has been a recipient of the joint Canadian Psychiatric Association (CPA)/Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.
Dr. McIntyre is a contributor to the Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder and Bipolar Disorder. Dr. McIntyre was the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the CANMAT guidelines for the treatment of depressive disorders and bipolar disorders. Dr. McIntyre has published more than 500 articles and manuscripts, and has edited and/or co-edited several textbooks on mood disorders.
Dr. McIntyre completed his medical degree at Dalhousie University, in Halifax, Nova Scotia, Canada. He received his psychiatry residency training and fellowship in psychiatric pharmacology at the University of Toronto.
Friday, October 4
12:15 PM – 1:30 PM
Friday, October 4
6:15 PM – 7:15 PM
Saturday, October 5
7:15 AM – 9:00 AM